Profil
Edward P.
Owens is currently a Director at Stealth BioTherapeutics Corp.
and Stealth BioTherapeutics, Inc. He previously served as an Independent Director at Ironwood Pharmaceuticals, Inc. and Escape Bio, Inc. He was also a Senior Vice President at Wellington Management Co. LLP and a Portfolio Manager at Vanguard Health Care Fund.
Owens has also served as a Trustee at The Marine Biological Laboratory.
He received his undergraduate degree from the University of Virginia and an MBA from Harvard Business School.
Postes actifs de Edward Owens
| Sociétés | Poste | Début |
|---|---|---|
| STEALTH BIOTHERAPEUTICS CORP | Directeur/Membre du Conseil | 22/06/2018 |
Stealth BioTherapeutics, Inc.
Stealth BioTherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies to treat the mitochondrial dysfunctions and age-related diseases | Directeur/Membre du Conseil | 01/05/2017 |
Anciens postes connus de Edward Owens
| Sociétés | Poste | Fin |
|---|---|---|
| IRONWOOD PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 01/06/2022 |
Wellington Management Co. LLP
Wellington Management Co. LLP Investment ManagersFinance WMC relies on their extensive independent research and includes portfolio management styles and approaches in equities, fixed income securities, currencies and commodities, as well as asset allocation across these categories. The firm has several different disciplines when approaching research and these include asset allocation analysts, currency analysts, data scientists, factor analysts, fixed income credit analysts, fixed income market analysts, global industry analysts and research associates, macro-analysts, quantitative analysts and technical analysts. | Analyst-Equity | 28/02/2013 |
Vanguard Health Care Fund
Vanguard Health Care Fund Investment Trusts/Mutual FundsMiscellaneous Exists as exchange Traded Fund | Corporate Officer/Principal | 01/12/2012 |
ESCAPE Bio, Inc.
ESCAPE Bio, Inc. BiotechnologyHealth Technology Develops small molecule therapeutics against genetic targets for neurodegenerative disease | Directeur/Membre du Conseil | - |
The Marine Biological Laboratory
The Marine Biological Laboratory Miscellaneous Commercial ServicesCommercial Services Provides research and educational services | Directeur/Membre du Conseil | - |
Formation de Edward Owens
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Wellington Management Co. LLP
Wellington Management Co. LLP Investment ManagersFinance WMC relies on their extensive independent research and includes portfolio management styles and approaches in equities, fixed income securities, currencies and commodities, as well as asset allocation across these categories. The firm has several different disciplines when approaching research and these include asset allocation analysts, currency analysts, data scientists, factor analysts, fixed income credit analysts, fixed income market analysts, global industry analysts and research associates, macro-analysts, quantitative analysts and technical analysts. | Finance |
Ironwood Pharmaceuticals, Inc.
Ironwood Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets gastrointestinal products | Health Technology |
University of Virginia
University of Virginia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Marine Biological Laboratory
The Marine Biological Laboratory Miscellaneous Commercial ServicesCommercial Services Provides research and educational services | Commercial Services |
Vanguard Health Care Fund
Vanguard Health Care Fund Investment Trusts/Mutual FundsMiscellaneous Exists as exchange Traded Fund | Miscellaneous |
Harvard Business School
Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ESCAPE Bio, Inc.
ESCAPE Bio, Inc. BiotechnologyHealth Technology Develops small molecule therapeutics against genetic targets for neurodegenerative disease | Health Technology |
Stealth BioTherapeutics Corp.
Stealth BioTherapeutics Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops investigational drugs for the treatment of diseases involving mitochondrial dysfunction | Health Technology |
Stealth BioTherapeutics, Inc.
Stealth BioTherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies to treat the mitochondrial dysfunctions and age-related diseases | Health Technology |
















